Sources say Stryker may have plans to buy division of Boston Scientific

08/17/2010 | Bloomberg

Stryker is in discussions to acquire Boston Scientific's neuromodulation business for about $1.5 billion, and an agreement over the unit may be disclosed next week, according to three people familiar with the potential deal. An analyst with Cannacord Genuity said the purchase would supplement Stryker's line of pain-management devices for back problems.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care